What is HP's health score?

Helmerich & Payne, Inc. (HP) has a TradeApes health score of 49 out of 100, rated Mixed. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is HP's estimated fair value?

Based on our 5-year discounted cash flow model, Helmerich & Payne, Inc.'s estimated fair value is $34.6 per share, representing a -7.7% downside from the current price. This is a model estimate, not a price target or investment recommendation.

Is HP undervalued or overvalued?

Our model currently rates HP as Fair Value. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for HP... Refresh in a moment for the full analysis.

Helmerich & Payne, Inc. (HP)

Energy Fair Value low mixed

$37.46

Updated: 2026-06-07

TradeApes Score

Financial Strength

30 Weak

Operating Trend

65 Healthy

Relative Value

30 Weak

Capital Allocation

65 Healthy

Risk

80 Strong

Est. Fair Value $34.6

DCF Upside -7.7%

Sector Rank #1469 of 2070

Key Findings

+ Strong revenue growth — sales up more than 20% year over year

Unlock Full Report →

− Historically expensive — EV/EBITDA in top 20% of its 5-year range

Unlock Full Report →

2 free score cards remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.